ClinicalTrials.gov
ClinicalTrials.gov Menu

Exenatide for Myocardial Protection During Reperfusion Study (EMPRES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01938235
Recruitment Status : Recruiting
First Posted : September 10, 2013
Last Update Posted : August 5, 2016
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Vladimír Džavík, University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : January 2018